Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

E Hanks, Gerald; F Pajak, Thomas; Porter, Arthur; Grignon, David; Brereton, Harmart; Venkatesan, Varagur; M Horwitz, Eric; Lawton, Colleen; A Rosenthal, Seth; M Sandler, Howard; U Shipley, William; Therapy Oncology Group, Radiation

doi:10.1200/jco.2003.11.023

Public

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

Shared by NobleBlocks on Nov 1, 2003 • 12:00 AM UTC

Authors:

Gerald E Hanks

Thomas F Pajak

Arthur Porter

Abstract

PURPOSE: Radiation Therapy Oncology Group (RTOG) Protocol 92-02 was a randomized trial testing long-term (LT) adjuvant androgen deprivation (AD) after initial AD with external-beam radiotherapy (RT) in patients with locally advanced prostate cancer (PC; T2c-4) and with prostate-specific antigen leve...

Discussions